Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
TAKEDA PHARMA A/S
A/S
Active
CVR 16406899
Delta Park 45, 2665
Vallensbæk Strand
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1984 · 42 years old
73 employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
TAKEDA PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
557M
1B
2B
2B
1.9B
2021
910M
2022
1.1B
2023
1.1B
2024
1.1B
2025
EBITDA
DKK millions
1220M
915M
610M
305M
0M
976M
2021
50M
-95%
2022
27M
-46%
2023
346M
+1181%
2024
23M
-93%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
1.939.231
910.058
1.061.206
1.118.710
1.102.419
Staff expenses
-159.395
-104.459
-93.146
-91.609
-96.205
EBITDA
975.501
49.530
27.436
346.095
22.830
Depreciation & amort.
22.641
-8.264
-6.594
-8.506
-5.582
EBIT
952.860
41.266
20.842
337.589
17.248
Net financials
-39.139
1.455
10
-1.862
-103
Profit before tax
913.721
42.721
20.852
335.727
17.145
Tax
245.977
10.926
7.279
74.505
4.983
Net profit
667.744
31.795
13.573
261.222
12.162
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
2.017.020
622.293
485.750
582.370
581.334
Equity
1.046.401
81.238
94.892
355.951
368.294
Long-term debt
18.134
14.219
12.659
10.701
9.360
Short-term debt
952.485
525.597
375.272
215.718
203.680
Total debt
970.619
539.816
387.931
226.419
213.040
Financial ratios
5-year trend
EBITDA-margin
2.1%
This company
15.8%
Market median
-87% vs market
2021
2025
Soliditetsgrad
63.4%
This company
38.2%
Market median
+66% vs market
2021
2025
Egenkapitalforrentning
3.3%
This company
18.4%
Market median
-82% vs market
2021
2025
Nettoresultatgrad
1.1%
This company
8.1%
Market median
-86% vs market
2021
2025
Aktivomsætning
1.90×
This company
1.12×
Market median
+70% vs market
2021
2025
Gæld/egenkapital
0.58×
This company
0.62×
Market median
+6% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
View
PDF
More on TAKEDA PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
